Benzinga | Mar 9, 2021 09:16AM EST

Avadel Pharmaceuticals Q4 EPS $(0.19) Beats $(0.27) Estimate

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 171.43 percent decrease over losses of $(0.07) per share from the same period last year.